In a previous video we compared brand name and generic drugs. But we kind of left out a major player in the world of medicines; biologic drugs. These complicated little guys probably deserve a video all to themselves. Call them what you will -biologics, biotherapeutic medicines, or biopharmaceuticals- they’re topic of this week’s HealthCare triage.
For those of you who want to read more:
- Comparison of EP2006, a Filgrastim Biosimilar, to the Reference: a Phase III, Randomized, Double-Blind Clinical Study in the Prevention of Severe Neutropenia in Patients with Breast Cancer Receiving Myelosuppressive Chemotherapy
- Does Generic Entry Always Increase Consumer Welfare?
- Are trade secrets delaying biosimilars?
- How to Decrease Prices for an Expensive Class of Drugs
P.S. Thanks to Rachel Hoffman, Healthcare Triage intern, for help with this episode!!!